NCT02061449View on ClinicalTrials.gov

Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 5, 2018

Study Completion Date

November 5, 2018

Conditions
Cutaneous T-cell Lymphoma
Interventions
DRUG

Romidepsin

DRUG

Poly ICLC

RADIATION

Focal lesional radiation

Trial Locations (1)

10016

NYU Cancer Institute, New York

Sponsors
All Listed Sponsors
collaborator

Ludwig Institute for Cancer Research

OTHER

lead

NYU Langone Health

OTHER